Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Le Min, M.Med., Ph.D.

Concepts (150)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Le Min's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Le Min has written about over time.
Melanoma, 6 publications between 2010 and 2016, average publication date September 2013. Antibodies, Monoclonal, 8 publications between 2010 and 2018, average publication date July 2014. Receptors, G-Protein-Coupled, 5 publications between 2012 and 2015, average publication date July 2014. Adrenal Cortex Hormones, 2 publications between 2014 and 2015, average publication date April 2015. Hypothyroidism, 3 publications between 2013 and 2019, average publication date December 2016. Endocrine System Diseases, 2 publications between 2018 and 2018, average publication date January 2018. Thyrotoxicosis, 2 publications between 2017 and 2019, average publication date August 2018. Thyroid Diseases, 3 publications between 2017 and 2019, average publication date October 2018. Addison Disease, 1 publications between 2019 and 2019, average publication date February 2019. Pituitary Neoplasms, 2 publications between 2017 and 2023, average publication date April 2020. Adenoma, 3 publications between 2017 and 2023, average publication date July 2020. Pituitary ACTH Hypersecretion, 1 publications between 2021 and 2021, average publication date January 2021. Diabetes Mellitus, Type 1, 3 publications between 2019 and 2024, average publication date June 2021.

To see the data from this visualization as text, click here.
Min's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (150)
Explore
_
Co-Authors (35)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.